Marine-derived compounds, including Echinochrome A, have also shown immunomodulatory effects, including the downregulation of IL-4 and IL-13, thus favoring the potential of marine bioactive compounds in the reduction of Th2-mediated inflammation in AD [26]. This evidence concerns the gene IL13 and Alzheimer disease.